Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells

Cells(2021)10.3390/cells10061363Source: DataRank Database

Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells is a research paper published in Cells (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.59)OA: goldTopics (39)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Yoshinobu Odaka ORCID,Zhu Huang ORCID,Bing Cheng ORCID,Wang Liu ORCID,Lin Li ORCID

Live enrichment

PubMed:34205996 OpenAlex:https://openalex.org/W3171892853

National Institutes of Health

Grant: CA115414

American Cancer Society

Grant: RSG-08-135-01-CNE

National Institutes of Health

Grant: 5R01CA115414-03

mTOR Signaling in Tumor Cell Motility

FWCI

0.59

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/10/6/1363/pdf?version=1622617652

publisherhttps://www.mdpi.com/2073-4409/10/6/1363/pdf?version=1622617652

publisherhttps://www.mdpi.com/2073-4409/10/6/1363/pdf

journalhttps://doi.org/10.3390/cells10061363

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34205996

Fields of Study

PI3K/AKT/mTOR signaling in cancerQuinazolinone synthesis and applicationsMast cells and histamine0301 basic medicine03 medical and health sciences

MeSH Terms

Mechanistic Target of Rapamycin Complex 1HumansNeoplasm ProteinsRhabdomyosarcomaSignal TransductionArtemisininsCell Line, TumorAMP-Activated Protein Kinases

Keywords

mTORC1AMPKPI3K/AKT/mTOR pathwayChemistryProtein kinase AProtein kinase BRHEBCancer researchCell biologyKinaseSignal transductionBiologyPTENQH573-671AMP-Activated Protein KinasesMechanistic Target of Rapamycin Complex 1ArticleArtemisininsNeoplasm ProteinsdihydroartemisininraptorCell Line, TumorRhabdomyosarcomamTORHumansCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being